Showing 1 - 3 results of 3 for search '"response rate"', query time: 0.03s Refine Results
  1. 1
    Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis

    Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-an... by Yin-Che Wang, Cheng-Hsien Lin, Yu-Chen Su, Chieh-Lin Jerry Teng

    Published 2025-12-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis

    Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherap... by Weiming Liang, Weiming Liang, Zhijing Wang, Zhilong Huang, Yanping Huang, Chunyan Li, Yiwen Liang, Miaoyan Huang, Duo Zhang, Chenchen Li

    Published 2025-02-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Evaluating the Effect of Monetary Incentives on Web Survey Response Rates in the UK Millennium Cohort Study

    Evaluating the Effect of Monetary Incentives on Web Survey Response Rates in the UK Millennium Cohort Study by Charlotte Booth, Erica Wong, Matt Brown, Emla Fitzsimons

    Published 2024-04-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: